MTB
65
2
BWA
46
2
TRV
56
3
TGNA
56
3
LMT
32
-12
AON
52
2
AMZN
55
-3
CI
52
7
CMI
64
5
CTAS
59
4
OMC
61
6
AKAM
50
7
BBY
36
-4
VNO
50
-9
PFG
42
3
URI
60
7
NKE
30
2
NAVI
47
3
AAL
53
-4
RHI
57
3
MTB
65
2
BWA
46
2
TRV
56
3
TGNA
56
3
LMT
32
-12
AON
52
2
AMZN
55
-3
CI
52
7
CMI
64
5
CTAS
59
4
OMC
61
6
AKAM
50
7
BBY
36
-4
VNO
50
-9
PFG
42
3
URI
60
7
NKE
30
2
NAVI
47
3
AAL
53
-4
RHI
57
3
Financhill
Back

Enfusion Vs. F5 Industry Stock Comparison

Buy
60

ENFN
Enfusion

Last Price:
10.36
Seasonality Move:
-19.59%
Buy
67

FFIV
F5

Last Price:
246.92
Seasonality Move:
2.22%
Buy
60
Enfusion (ENFN) is a Buy

Is Enfusion a Buy, Sell or Hold?

  • The current Enfusion [ENFN] share price is $10.10. The Score for ENFN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ENFN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
F5 (FFIV) is a Buy

Is F5 a Buy, Sell or Hold?

  • The current F5 [FFIV] share price is $244.29. The Score for FFIV is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • FFIV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ENFN Stock Price Chart

What is Enfusion's stock price today?

  • The Enfusion share price today is $10.10
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ENFN is experiencing buying pressure, which is a positive indicator for future bullish movement.

FFIV Stock Price Chart

What is F5's stock price today?

  • The F5 share price today is $244.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FFIV is experiencing slight buying pressure.

ENFN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.25 Buy
Relative Strength Index (14 RSI): 68.45 Buy
Chaikin Money Flow: 191865 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

FFIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.69 Buy
Relative Strength Index (14 RSI): 65.36 Buy
Chaikin Money Flow: 38686 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ENFN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.77 Buy
20-day SMA: 9.39 Buy
50-day SMA: 9.12 Buy
200-day SMA: 8.95 Buy
8-day EMA: 9.76 Buy
20-day EMA: 9.49 Buy
50-day EMA: 9.17 Buy
200-day EMA: 9.02 Buy

FFIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 242.16 Buy
20-day SMA: 237.39 Buy
50-day SMA: 225.62 Buy
200-day SMA: 193.26 Buy
8-day EMA: 241.4 Buy
20-day EMA: 236.79 Buy
50-day EMA: 225.62 Buy
200-day EMA: 197.9 Buy

Enfusion Earnings Growth & ENFN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.08 per share.

F5 Earnings Growth & FFIV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.73 per share, and an increase next year of $1.12 per share.

Enfusion Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

F5 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):